Vident Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.56M | Buy |
21,541
+1,260
| +6% | +$325K | 0.06% | 252 |
|
|
2025
Q1 | $4.54M | Buy |
20,281
+3,153
| +18% | +$706K | 0.07% | 259 |
|
|
2024
Q4 | $3.92M | Buy |
17,128
+982
| +6% | +$225K | 0.07% | 258 |
|
|
2024
Q3 | $3.94M | Buy |
16,146
+12,339
| +324% | +$3.01M | 0.1% | 204 |
|
|
2024
Q2 | $729K | Sell |
3,807
-2,805
| -42% | -$537K | 0.02% | 713 |
|
|
2024
Q1 | $1.31M | Buy |
6,612
+1,251
| +23% | +$248K | 0.03% | 499 |
|
|
2023
Q4 | $922K | Buy |
5,361
+3,535
| +194% | +$608K | 0.02% | 582 |
|
|
2023
Q3 | $270K | Buy |
+1,826
| New | +$270K | 0.01% | 971 |
|